In contrast to Spry3 and Spry2, Spry4 expression is inhibiting cell migration and proliferation of GBM-derived cell lines and is able to inhibit ERK phosphorylation in FGF2- and serum-induced as well as in unstimulated GBM-derived cells. The gene discussed is SPRY4; the disease is glioblastoma.